Literature DB >> 64375

Serum alpha-fetoprotein in patients with massive hepatic necrosis.

J R Bloomer, T A Waldmann, K R McIntire, G Klatskin.   

Abstract

Serum concentrations of alpha-fetoprotein (AFP) were measured by radioimmunoassay in 12 patients with massive hepatic necrosis, 11 of whom died. Levels were significantly elevated after the 8th day of illness in 8 of the 9 patients who died between the 10th and 60th day, and in the 1 patient who survived. All 9 patients with increased levels of serum AFP exhibited histological evidence of hepatic regeneration. These findings indicate that the rise in serum AFP in massive hepatic necrosis is related to the duration of survival after the onset of illness, but does not necessarily imply ultimate recovery. Because available evidence suggests that the serum AFP level reflects hepatic regenerative activity, it appears that the onset of regeneration in fulminant hepatitis is delayed until the 2nd week of illness.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 64375

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Primary clear cell carcinoma of noncirrhotic liver: immunohistochemical discrimination of hepatocellular and cholangiocellular origin.

Authors:  H E Adamek; A Spiethoff; V Kaufmann; R Jakobs; J F Riemann
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

2.  Serum alpha-fetoprotein in nonneoplastic liver diseases.

Authors:  J R Bloomer
Journal:  Dig Dis Sci       Date:  1980-04       Impact factor: 3.199

3.  Fulminant hepatic failure in childhood.

Authors:  S Parekh; S Rajadhyaksha; B Agarwal
Journal:  Indian J Pediatr       Date:  1985 Nov-Dec       Impact factor: 1.967

4.  Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: analysis of a double blind controlled trial.

Authors:  K Fujiwara; I Ogata; H Oka
Journal:  Gastroenterol Jpn       Date:  1989-04

5.  Circulating intercellular adhesion molecule 1 predicts non-specific elevation of alpha 1-fetoprotein.

Authors:  E Falleti; C Fabris; M Pirisi; G Soardo; D Vitulli; P Toniutto; E Bartoli; N Bortolotti; F Gonano
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  Serum alpha-fetoprotein in patients following partial hepatectomy.

Authors:  N Nagasue; K Inokuchi; M Kobayashi; R Kanashima
Journal:  Dig Dis Sci       Date:  1980-04       Impact factor: 3.199

7.  Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma.

Authors:  Hana Park; Jun Yong Park
Journal:  Biomed Res Int       Date:  2013-12-29       Impact factor: 3.411

8.  Distinct inflammatory mediator patterns characterize infectious and sterile systemic inflammation in febrile neutropenic hematology patients.

Authors:  Christine Wennerås; Lars Hagberg; Rune Andersson; Lars Hynsjö; Anders Lindahl; Marcin Okroj; Anna M Blom; Peter Johansson; Björn Andreasson; Johan Gottfries; Agnes E Wold
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

9.  Value of Liver Regeneration in Predicting Short-Term Prognosis for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure.

Authors:  Xiaoping Wang; Mengying Sun; Xianjun Yang; Liucun Gao; Min Weng; Dehui Yang; Hongyong Li; Xiaolei Zhou; Jiani Li; Sen Qin; Dejiang Zhou; Xiaoling Wu; Shanhong Tang; Weizheng Zeng
Journal:  Biomed Res Int       Date:  2020-08-06       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.